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Edited by Ga´spa´r Je´kelyAbstract The interactions between the TCR and peptides
bound to class I MHC encoded molecules (pMHC) and a mech-
anism for CD8 cooperation in this process are reviewed. Obser-
vation of two TCR/CD8 populations with diﬀerent lateral
diﬀusion rate constants as well as two distinct association phases
of class I MHC tetramers ((pMHC)4) with T-cells suggest that
the most eﬃcient pMHC–T-cell association route corresponds to
a fast tetramer binding to a colocalized CD8/TCR population,
which apparently resides within membrane rafts. Thus, ligand–
cell association starts by pMHC binding to the CD8. This rather
fast step promotes pMHC association with CD8–proximal
TCRs and thereby enhances the overall association process.
The model suggests that this raft-associated CD8–TCR subpop-
ulation is responsible for evoking T-cell activation.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Recognition of pathogen-infected cells is a central and cru-
cial function of the T-cells compartment of the immune system
[1,2]. This process is essential for launching and directing its
function of eliminating the infected cells. Thus, T-lymphocytes
are screening the bodys own cells, resolving between the
healthy and the pathogen-infected ones. This is a particularly
challenging task since pathogens such as viruses, usually reside
inside the infected cells and leave no marks on the cells sur-
faces. Evolution devised a recognition mechanism, which takes
advantage of the ongoing process of recycling which all cellu-
lar proteins undergo: protein fragments (peptides) get bound
to molecules encoded by the class 1 and 2 major histocompat-
ibilty complex (MHC) and are expressed on all the bodys cells
surfaces [3]. T-cells carry on their surfaces the T-cell antigen
receptors (TCR) [4] which have developed to identify and bind
the MHC complexes containing peptides (pMHC) of foreign
origin [5]. Already the interaction between TCR and pMHC
has unusual features: they exhibit exquisite speciﬁcity to the
structure of the pMHC yet are mostly endowed with a rela-*Corresponding author.
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doi:10.1016/j.febslet.2005.04.025tively low aﬃnity (104–106 M1). In addition, TCR exhibits
a remarkable cross-reactivity such that a single T-cell clone
could recognize a number of peptides that diﬀer signiﬁcantly
in their primary sequence [6]. The interaction of pMHC with
the co-receptor CD8 is independent of the antigenic peptide
structure, since it is taking place between the constant domains
of the TCR and the MHC yet is characterized by signiﬁcantly
lower aﬃnity (104 M1). Though both these interactions
are of such low aﬃnity, T-cells can be activated at extremely
low levels of ligand expression on the surface of the antigen
presenting cells (APC). Namely less than dozen copies of cog-
nate pMHC per cell suﬃce for activation [7]. Moreover, strong
agonist–peptide–MHC complexes activate T-cells without the
involvement of CD8–pMHC interaction, whereas for weak
ones, this interaction is necessary [8]. A molecular rationale
for the role of CD8 cooperation with the TCR is still debated.
It is assumed that both molecules are randomly distributed in
the membrane and CD8 associates with the TCR–pMHC com-
plex if it is suﬃciently long-lived. Then, the CD8-associated
protein tyrosine kinase Lck initiates the TCR signaling cascade
by phosphorylating the f-chain of the TCR-associated CD3
complex [9]. CD8 binding to the pMHC may also stabilize
the TCR–pMHC interaction and thereby increase T-cell sensi-
tivity. This however does not explain why strong agonists were
shown to activate T-cells without CD8 involvement and how
the rather low aﬃnity of CD8–pMHC interaction signiﬁcantly
enhances stability of TCR–pMHC complexes.
Here, we review our eﬀorts at resolving the mechanism of
interactions between the TCR, its coreceptor CD8 and their li-
gand, pMHC. To this end, detailed measurements have been
carried out of the mobility of the TCR and CD8 on the T-cells
surface as well as of both their association and dissociation
kinetics with the pMHC ligand. In addition, we review kinetic
measurements of the binding and dissociation of pMHC com-
plexes to and from the TCR that were performed on their re-
combinant, water-soluble derivatives. Finally, we present and
discuss a possible mechanism based on our results, which
may rationalize the cooperation between TCR and CD8 that
endows T-cells with their remarkable sensitivity.2. Interactions of soluble TCR, CD8 and pMHC exhibit unusual
time-courses
2.1. TCR–pMHC association
The interactions between recombinant water-soluble TCR
and pMHC have been extensively studied (cf. reviews byblished by Elsevier B.V. All rights reserved.
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were carried out using the surface plasmon resonance (SPR)
method (BiaCore) and in practically all, the results were ana-
lyzed in terms of a simple bi-molecular reaction mechanism.
Typically, the calculated second-order association rate con-
stant kon was found to be in the 10
3–104 M1 s1 range. These
values are signiﬁcantly slower that those determined for
antibody–hapten [12–14] or peptide–MHC binding (106
M1 s1) [15–17]. The dissociation rate constants of the
TCR–pMHC interactions were similarly calculated to be in
the 0.01–0.2 s1 range. These data suggest that the TCR–
pMHC complexes form with unusually slow rates for simple
bi-molecular processes. Thus, two proteins interacting by an
essentially diﬀusion-controlled process were indeed found to
react with an association rate constant 105 M1 s1 [18].
An important feature of this TCR–MHCp association phase
is that being rather slow, it is markedly aﬀected by the rela-
tively fast dissociation process: Assuming the operation of a
reversible, single step reaction mechanism, one can calculate
that k1 Æ [TCR] 6 k1. This results in a slight concentration
dependence of the observed apparent association rate constant
kap = k1 Æ [TCR] + k1. Therefore, employing this model for
the data analysis does not yield a unique solution.
In order to rationalize the relatively large body of published
kinetic and structural results, we have examined whether the
TCR–MHCp interactions could be described by either of the
following two related mechanisms. One describes an induced-




pMHC  TCRint ¢k23
k32
pMHC  TCRst ð1Þ
The other mechanism assumes the existence of two distinct






pMHC  TCR ð2Þ
A rather good agreement between TCR–pMHC kinetic
data and these two models has been established [19]. Thus,
the induced-ﬁt model suggests that the association reaction
starts by forming an initial intermediate complex (TCR–
MHCp)int at a rate close to a diﬀusion-controlled process.
This initial complex undergoes a transformation step that
produces a more stable complex, which determines the over-
all association rate. This second step has so far not been ob-
served because of the limited time resolution of the SPR
method. Since this step involves a ligand-induced conforma-
tional transition in the TCR, its rate may also be a function
of the ligands structure, including that of the bound pep-
tide. This can rationalize the remarkable T-cell speciﬁcity,
which allows resolution between two MHC complexes with
peptides diﬀering by only one amino acid residue [20,21].
The alternative model which assumes the existence of two
free site conformers (Eq. (2)), only one of which binds spe-
ciﬁcally the MHCp ligand, reﬂects the ﬂexibility of the TCR
binding site. By switching conformations, the binding site
can screen structures of potential ligands. In addition, these
properties may also provide a rational for the known
remarkable combination of exquisite speciﬁcity and cross-
reactivity of TCRs [6].
In order to discriminate between the above mechanisms
underlying the TCR–pMHC interactions, binding experimentsshould be carried out at ligand concentrations of tens–hun-
dreds micromolar range where the dissociation will not signif-
icantly aﬀect the binding phase. This may allow a better
examination of the association phase concentration depen-
dence. Furthermore, one could expect to resolve a bi-phasic
association time-course under these experimental conditions.
Concentration dependence of these steps may allow diﬀerenti-
ation between the ‘‘induced-ﬁt’’ and ‘‘conformational pre-equi-
librium’’ mechanisms. Such measurements do however require
millisecond temporal resolution and therefore cannot by per-
formed by commercial SPR instruments. Hence, this problem
demands the development of diﬀerent experimental systems
enabling direct monitoring of these reactions in the required
time resolution.2.2. CD8–pMHC association
CD8 is encoded by two distinct genes yielding its two dis-
tinct subunits; CD8a and CD8b and is expressed either as
CD8aa homodimer or as CD8ab heterodimer. In spite of
its importance, relatively limited data are available on the
mechanism of CD8–pMHC interaction. Moody et al. [22]
measured equilibrium dissociation constants for the interac-
tion of mouse CD8 homo and heterodimers with diﬀerent
MHC alleles. Aﬃnity of the heterodimer was slightly al-
lele-dependent, 140 mM for H-2Kb and 200 mM H-2Db. A
similar value (100 lM) was reported for mouse CD8ab–H-
2Kd interaction [23]. Wyer et al. [24] reported 126 lM for
the equilibrium constant and 18 s1 for the dissociation rate
constant (koﬀ) of human CD8aa–HLA-A2 interaction, both
determined by SPR. However, the actual value of the latter
could be even faster due to possible rebinding expected for a
high surface density of the immobilized ligand. The value of
kon calculated as a ratio of koﬀ and the equilibrium dissoci-
ation constant Kd, was found to be 1.4 · 105 M1 s1,
which, again may actually be faster due to the possible
rebinding. These results indicate that the aﬃnity of CD8–
pMHC interaction is only slightly dependent on species or
allele type and falls in the 100–200 lM range. Signiﬁcantly,
this association is assumed to reﬂect rigid bodies interactions
as no evidence for additional reaction steps has been
reported.2.3. CD8 and TCR bind the pMHC independently
Wyer et al. [24] have also studied the interactions between
a pMHC complex immobilized on the surface of the BIA-
CORE chip and TCR alone, or in the presence of a high
concentration CD8aa (120 mM). These experiments revealed
that the TCR binding and dissociation time-courses were
independent of the presence of CD8 molecules in the reac-
tion mixture. Based on these observations the authors con-
cluded that there is no cooperativity in CD8 and TCR
interactions with their pMHC ligand, i.e., CD8–pMHC
interaction does not aﬀect the aﬃnity of the TCR–pMHC
interaction, and CD8 and TCR bind the antigen indepen-
dently. This however does not exclude the possibility of
CD8 involvement in pMHC binding on the cell-surface that
can inﬂuence the process in a diﬀerent way. In order to ad-
dress this problem, we have ﬁrst studied the lateral diﬀusion
of CD8 and TCR in the cell-surface membrane and comple-
mented these investigations then by real-time measurement
of the interactions between pMHC and T-cells.
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is a heterogeneous process
In order to understand how CD8 and TCR interact with
pMHC on the cells membrane, knowledge of the lateral diﬀu-
sion of both former molecules is necessary. This was investi-
gated by ﬂuorescence correlation spectroscopy (FCS) [25–28].
This method is based on monitoring intensity ﬂuctuations of
a ﬂuorescence probe carried by a molecule of interest in an ex-
tremely small volume (0.2 ﬂ) illuminated by a sharply focused
laser beam on the cell surface. An important advantage of this
method is that it requires only microwatt levels of laser excita-
tion and low level staining of the membrane proteins with ﬂuo-
rescently labeled antibodies and therefore is less invasive than
the method based on monitoring ﬂuorescence recovering after
photobleaching. The autocorrelation function calculated from
the monitored ﬂuorescence ﬂuctuations is then used to calcu-
late the diﬀusion rate constants of the ﬂuorescently labeled
molecules.
Both CD8 and TCR molecules were found to exhibit het-
erogeneous diﬀusion patterns: fast and slow diﬀusing popu-
lations were observed for each of the molecules, yet with
very similar diﬀusion rate constants (e.g., 0.8 ± 0.3 and
0.05 ± 0.03 lm2/s). The fast constant has been assigned to
their diﬀusion in disordered membrane domains whereas
the slower one to that in the ordered membrane domains
[29]. Independent confocal microscopy measurements have
also suggested a distribution of both CD8 and TCR mole-
cules between rafts and disordered membrane microdomains:
A partial localization of these molecules within lipid raft do-
mains has been observed by us [29] and by other studies
[30–34].4. T-cells interaction with the pMHC involves CD8: studies
employing pMHC tetramers
4.1. Equilibrium binding of pMHC tetramers to T-cells
In order to investigate the possible role of CD8 in
pMHC–TCR binding on the cell-surface a novel approach
had to be developed. The short life span of TCR com-
plexes with monomeric soluble pMHC does not allow
monitoring these by ﬂow-cytometry. Hence, due to their
avidity tetramers of pMHC complexes labeled with ﬂuores-
cent probe became an invaluable tool for direct investiga-
tion of T-cell–pMHC interactions [35] and allow direct
analysis of antigen-speciﬁc T-cells [36]. Interestingly, no
direct correlation between TCR aﬃnity and T-cell cytotox-
icity has been observed in results of equilibrium tetramer-
binding experiments [37,38]. This has been an apparent
reﬂection of cell-surface CD8–TCR cooperation in pMHC
binding [39,40]. These reports clearly demonstrated that
involvement of CD8–pMHC interaction signiﬁcantly in-
creases the binding amplitude of the tetramer to T-cells.
However, the observed several-fold enhancement of tetra-
mer-binding amplitude to T-cells could not be rationalized
by an additive CD8 and TCR cooperation, since aﬃnity
of CD8–pMHC interaction was found to be about two or-
ders of magnitude lower that that of TCR–pMHC interac-
tion. Thus, a more complex mechanism for CD8 and TCR
cooperation had to be considered.4.2. Kinetic analysis of pMHC tetramers binding to T-cells
The observation by FCS measurements of two major com-
ponents in the diﬀusion of TCR and CD8 molecules led us
to suggest that these are due to distinct populations existing
on the cells membrane. In order to further investigate their
interactions with the pMHC ligand, cell-association and disso-
ciation time-courses of pMHC tetramers were carried out.
Results of real-time ﬂow cytometry measurements of tetra-
mer binding to T-cells provided the ground for a mechanism
of CD8–TCR cooperation in the interactions with the pMHC
ligand. This mechanism also rationalizes the above-described
apparent contradictions: It explains in particular why the
amplitude of tetramer binding to T-cells does not always cor-
relate with aﬃnity of TCR–pMHC interaction, and how CD8–
pMHC aﬃnity which is about two-orders of magnitude lower
than that the TCR–pMHC yields several-fold enhancement of
the amplitude of tetramer binding to T-cells.
The ﬂow cytometry measurements revealed that pMHC tet-
ramers associate with T-cells in a bi-phasic time-course for all
three diﬀerent T-cell types examined (two CTL clones and one
T-cell hybridoma) [29]. The fast phase rate constant was about
an order of magnitude faster than that of the slow one. The
fast phase disappeared when the cells were ﬁrst reacted with
a CD8-speciﬁc mAb that abrogates the CD8–pMHC interac-
tion. This clearly illustrated the involvement of CD8 in the fast
phase of pMHC tetramers–cell association.
In order to try and understand whether the CD8-involve-
ment is related to its own mobility or that of the TCR as mon-
itored by the FCS measurements, the cells were treated with
methyl-b-cyclodextrin (MbCD), a reagent known to deplete
cholesterol from the membrane and aﬀect the rafts structure
[41,42]. The cholesterol depletion slowed down the fast phase
binding rate by ca. 10-fold [29]. This suggested that the CD8
and TCR molecules involved in the fast tetramer association
step probably reside in rafts.
In further analyzing the tetramer–cells association process,
we had to take into account that the initial binding step of
any soluble ligand proceeds in three dimensions, i.e., from bulk
solution to the cell surface. Assuming also that this ﬁrst step
determines the rate of the overall reaction and its experimen-
tally observed rate is a pseudo-ﬁrst order one (i.e., a product
of the speciﬁc rate constant, k1, and tetramer concentration),
a value of k1 as (1.7 ± 0.2) · 105 M1 s1 at 24 C was calcu-
lated. This value was found to be essentially the same for all
three examined cell types, suggesting that CD8 molecules asso-
ciate with pMHC-tetramers loaded with diﬀerent peptides at
the same rate and hence this step is not clone-speciﬁc. More-
over, these rates are close to that reported for the association
rate constant of soluble CD8 and pMHC molecules (1–
2 · 105 M1 s1) [24], yet are much faster than that of H-
2Kd/pPbCSABA-binding to the T1 TCR (7.0 · 103 M1 Æ s1)
[19] both recombinant water-soluble reagents. All these lead
to the conclusion that the observed fast phase of tetramer–cell
association is primarily due to a process starting by (pMHC)4
association with the CD8. It is followed by association of the
CD8–(pMHC)4 complex with an additional one (or two)
CD8 molecules and with at least one TCR. As the rate of this
ﬁrst step is assumed to determine the overall tetramer–cells
binding rate, the rates of the following steps, all proceeding
on the cell surface, should be faster than the dissociation rate
constant of the CD8–(pMHC)4 complex. This however is only
possible if CD8 and TCR are colocalized, i.e., when the
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complex does not require lateral diﬀusion. Thus, our data have
suggested that at least some of the CD8 and TCR molecules
are proximal and reside in rafts, representing those molecules
observed as the slow diﬀusing population in the FCS measure-
ments. The slow binding phase has then been assigned to tet-
ramers interactions with the CD8 and TCR separated by a
suﬃciently large distances so that interaction with the same
pMHC ligand requires their lateral diﬀusion.
Tetramer dissociation from the cells was also found to be bi-
phasic when both CD8 and TCR were available for interac-
tion. The fast dissociation phase amplitude comprised ca.
80–90% of the total dissociation amplitude. The rate constant
of this phase was 7–10-fold faster than that of the slow disso-
ciation phase. The bi-phasic time-course was interpreted as dis-
sociation of tetramers having multiple CD8 interactions and
diﬀering in the number of pMHC–TCR interactions: one for
the faster dissociation phase and two or three for the slower
ones. In experiments, where the CD8–pMHC interactions were
blocked by the speciﬁc mAb and only the TCRs could interact
with the tetramers, a single dissociation phase has been ob-
served with a rate close to that of the slow phase in the exper-
iments where both CD8 and TCR were available for
interaction. These results imply that when tetramers are
associated with the T-cells by several TCR–(pMHC)4 con-
tacts, their life span is virtually independent of CD8–pMHC
interaction.5. Mechanism of pMHC association with T-cells
Taking together the experimental results of the kinetics of
interaction between soluble and cell-surface expressed TCR
and CD8 with their pMHC ligand and those of the lateral
mobility, provide a basis for a model describing the mecha-
nism the pMHC–T-cell interactions. As discussed above, the
elementary steps of association of soluble pMHC with the
TCR have not been resolved so far, yet it is assumed to pro-
ceed at a relatively slow rate due to conformation transitions
in the TCR binding site [43–46]. The latter are apparently
central for attaining high speciﬁcity in the antigen recogni-
tion. However, due to this slow binding and the relatively
fast dissociation rates, the reaction yield would be rather
low at low concentration levels of the reactants. However,
at the cell–cell interface, involvement of additional mole-
cules, notably the CD8, in the association will therefore sig-
niﬁcantly accelerate TCR–pMHC association and thereby
increase the reaction yield. First reason for this is the high
association rate constant of CD8 with the pMHC. Thus,
for CD8 proximal TCRs, the initial CD8–pMHC association
would signiﬁcantly increase the number of TCR–pMHC
complexes and accelerate thereby the overall association
rate. This process however would obviously be very sensitive
to the CD8–TCR separation distance due to the short life
span of the CD8–pMHC complexes. Thus, proximity of
TCR and CD8 on their surface provides T-cells with a un-
ique combination of functional properties: An exquisite spec-
iﬁcity complemented with high sensitivity. Another
advantage of the involvement of both these two molecules
in antigen recognition is that diﬀerent T-cells having the
same aﬃnity of their TCR for a given pMHC ligand cansigniﬁcantly modulate the association rate by the extent of
CD8–TCR proximity and thereby regulate their responsive-
ness. The proportion of the proximal and distal CD8 and
TCR molecules can therefore determine the capacity of a
T-cell to respond to APCs carrying either low or high levels
of cognate pMHC complexes.
The above hypothesis naturally raises the question of how is
the CD8 and TCR proximity regulated? One possibility is that
mobility of raft-resident CD8 and TCR molecules is limited
within the rafts area and therefore the CD8–TCR separation
distance will be determined by the raft size, which is 10–
50 nm [47]. Another possibility is a constitutive association
of CD8 and TCR for which experimental evidence has been re-
ported [48].
The above-proposed mechanism of CD8–TCR cooperation
also explains how the weaker CD8–pMHC interaction com-
pared with the TCR–pMHC one, has such a strong contribu-
tion in T-cell activation [49]. As suggested above, the pMHC
complex formation with proximal CD8 and TCR is assumed
to proceed at the rate determined by the CD8–pMHC associ-
ation. This is usually an order of magnitude faster than that of
the initial TCR–pMHC association and the CD8–pMHC–
TCR complex dissociates slightly slower than the TCR–
pMHC complex. Therefore, involvement of TCR–proximal
CD8 molecules may increase the aﬃnity of pMHC–cell inter-
action by the factor larger than the ratio of the association rate
constants of CD8–pMHC and TCR–pMHC but not in pro-
portion to the CD8–pMHC and TCR–pMHC aﬃnities. This
CD8 contribution is expected to increase sensitivity in propor-
tion to the number of TCR–proximal CD8 molecules on the
cell surface. This proportion between the raft and bulk resident
CD8/TCR populations was found to depend of the time past
after T-cell activation [29].6. Are the raft-resident-proximal CD8/TCRs the responsive
ones?
The experimental resolution of two distinct CD8/TCR pop-
ulations which interact with the pMHC ligands with about an
order of magnitude diﬀerent rates led us to suggest a mecha-
nism controlling sensitivity of T-cells response to the TCR
stimulus [29]. This was based on measurements of tetramer
binding to CTL clones on diﬀerent days after cell stimulation.
Maximal binding amplitudes were observed on those days
where expression of CD8 and TCR molecules was the highest
(3–4 post-stimulation (PS) days). Amplitude of the slow bind-
ing phase decreased with time elapsed after stimulation in par-
allel to a decrease in the CD8 and TCR expression levels.
However, in spite of the 50% decrease in the tetramer-bind-
ing amplitude on late PS days (10–12), the cytotoxicity virtu-
ally remained at the same level for over the 3–12 PS day
period. These results demonstrate that only the amplitude of
the fast binding phase correlates with the cytotoxicity and sug-
gests therefore that only the fast binding CD8/TCR population
is causing cells response. This ﬁnding explains why the total
tetramer-binding amplitude does not always correlate with
TCR–pMHC aﬃnity [37,38]. This mechanism suggested by
us [29] for modulation of T-cell sensitivity based on CD8–
TCR cooperation can therefore also explain how optimization
of the cellular immunity can be achieved without expansion of
3340 I. Pecht, D.M. Gakamsky / FEBS Letters 579 (2005) 3336–3341diﬀerent T-cell clones bearing receptors with higher aﬃnity for
antigen [50,51].
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